Physicochemical characterization and in vitro behavior of daunorubicin-loaded poly(butylcyanoacrylate) nanoparticles
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Chemotherapy-related skin toxicity · Chemotherapy-induced organ toxicity mitigation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. The anthracyclines: will we ever find a better doxorubicin?
2. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity10.1124/pr.56.2.6 ↗
3. Anthracycline drug targeting: cytoplasmic versus nuclear – a fork in the road10.1054/drup.2001.0201 ↗
4. Arcamone · 1981 · vol. 7
5. Sequential mitoxantrone, daunorubicin and cytosine arabinoside for patients with newly diagnosed acute myelocytic leukemia10.1002/(SICI)1096-8652(199712)56:4<214::AID-AJH3>3.0.CO;2-# ↗
6. Di Marco · 1974 · 101
7. Anthracycline antibiotics, new analogues, methods of delivery and mechanisms of action
8. Nanoparticles – a historical perspective10.1016/j.ijpharm.2006.10.021 ↗
9. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles10.1007/BF00877245 ↗
10. Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer10.1016/0378-5173(96)04559-0 ↗
11. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action10.1038/bjc.1997.362 ↗
12. Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages10.1023/A:1018902031370 ↗
13. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles10.1016/S0142-9612(99)00125-8 ↗
14. Enhanced cytotoxicity and nuclear accumulation of doxorubicin-loaded nanospheres in human breast cancer MCF7 cells expressing MRP1
15. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles10.1016/j.jconrel.2003.08.005 ↗
16. A computationally derived structural model of doxorubicin interacting with oligomeric polyalkylcyanoacrylate in nanoparticles10.1016/S0168-3659(03)00177-9 ↗
17. Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines10.1016/0165-4608(92)90204-L ↗
18. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)10.1016/S0959-8049(98)00045-8 ↗
19. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance10.1002/(SICI)1097-0215(19970529)71:5<907::AID-IJC33>3.0.CO;2-1 ↗
20. International Standard ISO13321. Methods for determination of particle size distribution part 8: photon correlation spectroscopy. Geneva: International Organization for Standardization; 1996.
21. General atomic and molecular electronic structure system10.1002/jcc.540141112 ↗
22. Electrostatic interaction of a solute with a continuum. A direct utilization of ab initio molecular potentials for the prevision of solvent effects10.1016/0301-0104(81)85090-2 ↗
23. The IEF version of the PCM solvation method: an overview of a new method addressed to study molecular solutes at the QM ab initio level10.1016/S0166-1280(98)00553-3 ↗
24. Frisch MJ et al. Gaussian 98, revision A.7. Pittsburgh, PA: Gaussian, Inc.; 1998.
25. Self-consistent perturbation theory of diamagnetism. I. A gauge-invariant LCAO (Linear Combination of Atomic Orbitals) method for NMR chemical shifts10.1080/00268977400100711 ↗
26. Efficient implementation of the gauge-independent atomic orbital method for NMR chemical shift calculations10.1021/ja00179a005 ↗
27. Acid phosphatase: endpoint for in vitro toxicity tests10.1007/BF02630912 ↗
28. Structure–activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition. Identification of novel chemotherapeutic drug resistance modulators10.1016/S0959-8049(02)00128-4 ↗
29. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerizaion and particle formation
30. Physical properties of anthraquinone and its derivatives. Part 1. Infrared spectra10.1039/jr9590000178 ↗
31. 1H NMR and IR spectra of antitumour anthracyclines: effect of the substitution pattern on the chemical shift values of the phenolic protons and on IR absorptions of the quinone system10.1002/mrc.1260230513 ↗
32. Self-association of daunomycin10.1021/bi00260a004 ↗
33. A proton nuclear magnetic resonance investigation of the conformation of daunomycin10.1016/0009-2797(96)03693-9 ↗
34. Hetero-association of anticancer antibiotics in aqueous solution: NMR and molecular mechanics analysis10.1016/j.bpc.2005.03.014 ↗
35. Self-association of daunomycin antibiotic in various buffer solutions10.1134/S003602440605013X ↗